论文部分内容阅读
目的研究胃癌患者外周血单个核细胞(PBMC)由细菌内毒素(LPS)诱导产生TNFα的能力及胃癌患者自身血浆和吲哚美辛对产生TNFα的影响.方法采用ELISA法测定36例胃癌患者(男27例,女9例,年龄38岁~71岁,平均52岁;其中,Ⅰ、Ⅱ期17例,Ⅲ、Ⅳ期19例);20例良性胃病患者(男13例,女7例,年龄32岁~75岁,平均49岁);及20例正常人(男12例,女8例,年龄25岁~52岁,平均47岁)PBMC经LPS诱导培养上清液中TNFα水平.胃癌患者PBMC又给予另外两种处理:胃癌自身血浆+LPS和吲哚美辛+LPS.结果TNFα水平(μg/L)胃癌组(304±166)较良性胃病组(103±062)与正常组(076±057)均显著升高(P<005),良性胃病组与正常组之间无显著差异(P>005);胃癌患者的不同病理分型间、分期间亦无显著差异(P>005).胃癌组PBMC经LPS诱导加自身血浆处理则TNFα水平较仅用LPS诱导者显著下降(207±094,P<005),而经吲哚美辛处理较仅用LPS处理者显著升高(64±306,P<001).结论TNFα水平可作为胃癌诊断的潜在标?
Objective To investigate the ability of peripheral blood mononuclear cells (PBMCs) from gastric cancer patients to induce TNFα production by bacterial endotoxin (LPS) and the effects of autologous plasma and indomethacin on TNFα production in gastric cancer patients. Methods Thirty-six patients with gastric cancer were detected by ELISA (27 males and 9 females, aged 38 to 71 years, mean 52 years; 17 of them were in stage I and II, 19 of stage III and IV); 20 cases of benign gastropathy Patients (13 males and 7 females, aged 32 to 75 years old, average 49 years old); and 20 normal subjects (12 males and 8 females, aged 25 to 52 years, mean 47 years) PBMCs via LPS Induced TNFα levels in the culture supernatant. Patients with gastric cancer PBMC were given two additional treatments: gastric autologous plasma + LPS and indomethacin + LPS. Results The level of TNFα (μg/L) in gastric cancer group (304±166) was significantly higher than that in benign gastropathy group (103±062) and normal group (076±057) (P <005), There was no significant difference between benign gastropathy group and normal group (P>005); There was no significant difference between different pathological types and periods of gastric cancer patients (P>005). In the gastric cancer group, PBMC induced by LPS and treated with autologous plasma had significantly lower levels of TNFα than those induced by LPS only (207±094, P<005), whereas treatment with indomethacin was more effective than LPS alone. Significantly increased (64±306, P<001). Conclusion The level of TNFα can be used as a potential marker for the diagnosis of gastric cancer.